Previous data in a pancreatic cancer model showed the existence of both the plasma membrane and a mitochondrial variant of ASCT2, which was suggested to be critical for glutamine-dependent mTORC1 activation required for cell survival (Yoo et al, 2020). The gene discussed is SLC1A5; the disease is pancreatic neoplasm.